IL6 and glioma: In our study only few patients had elevated IL-6 and YKL-40 compared to historical healthy controls indicating that systemic IL-6 and YKL-40 levels may not be key mediators in glioma-associated systemic immune modulation at time of surgery or that individual changes are more important than the absolute plasma concentration.